Viktor Wintzell

Om mig
Publikationer
CV
Populärvetenskap och samverkan

Om mig

See English site.

Artiklar

Article: JAMA INTERNAL MEDICINE. 2024;184(11):1301-1312
GLP-1 Receptor Agonist Use and Risk of Suicide Death
Ueda P; Soderling J; Wintzell V; Svanstrom H; Pazzagli L; Eliasson B; Melbye M; Hviid A; Pasternak B
Article: EUROPEAN HEART JOURNAL (EHJ) - CARDIOVASCULAR PHARMACOTHERAPY. 2024;10(5):432-443
Comparative cardiovascular and renal effectiveness of empagliflozin and dapagliflozin: Scandinavian cohort study
Engstrom A; Soderling J; Hviid A; Eliasson B; Gudbjornsdottir S; Wintzell V; Hveem K; Jonasson C; Melbye M; Pasternak B; Ueda P
Article: CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 2024;22(6):1226-1237.e14
Use of DPP4 Inhibitors and GLP-1 Receptor Agonists and Risk of Intestinal Obstruction: Scandinavian Cohort Study
Ueda P; Wintzell V; Melbye M; Eliasson B; Soderling J; Gudbjornsdottir S; Hveem K; Jonasson C; Svanstrom H; Hviid A; Pasternak B
Article: HEPATOLOGY. 2024;79(6):1401-1411
Association of glucagon-like peptide-1 receptor agonists with serious liver events among patients with type 2 diabetes: A Scandinavian cohort study
Engstrom A; Wintzell V; Melbye M; Svanstrom H; Eliasson B; Gudbjornsdottir S; Hveem K; Jonasson C; Hviid A; Ueda P; Pasternak B
Article: THORAX. 2024;79(5):395-402
Use of inhaled corticosteroids and the risk of hospitalisation for pneumonia in children with asthma: a nationwide cohort study
Kamgang K-HS; Rhedin SA; Almqvist C; Wintzell V
Article: THE BMJ. 2024;385:e078225
Glucagon-like peptide 1 receptor agonist use and risk of thyroid cancer: Scandinavian cohort study
Pasternak B; Wintzell V; Hviid A; Eliasson B; Gudbjornsdottir S; Jonasson C; Hveem K; Svanstrom H; Melbye M; Ueda P
Article: DIABETES CARE. 2023;46(2):351-360
Sodium-Glucose Cotransporter 2 Inhibitor Treatment and Risk of Atrial Fibrillation: Scandinavian Cohort Study
Engstroem A; Wintzell V; Melbye M; Hviid A; Eliasson B; Gudbjoernsdottir S; Hveem K; Jonasson C; Svanstroem H; Pasternak B; Ueda P
Article: EPIDEMIOLOGY. 2022;33(5):707-714
Selection of Comparator Group in Observational Drug Safety Studies: Alternatives to the Active Comparator New User Design
Wintzell V; Svanstrom H; Pasternak B
Article: CLINICAL AND TRANSLATIONAL SCIENCE. 2022;15(5):1112-1122
Proton pump inhibitor use and risk of depression and anxiety in children: nationwide cohort study
Wang Y-H; Wintzell V; Ludvigsson JF; Svanstrom H; Pasternak B
Article: BMJ OPEN. 2022;12(4):e060771
Association between proton pump inhibitor use and risk of pneumonia in children: nationwide self-controlled case series study in Sweden
Wang Y-H; Svanstrom H; Wintzell V; Ludvigsson JF; Pasternak B
Article: DIABETES, OBESITY AND METABOLISM. 2022;24(3):473-485
The comparative cardiovascular and renal effectiveness of sodium-glucose co-transporter-2 inhibitors and glucagon-like peptide-1 receptor agonists: A Scandinavian cohort study
Ueda P; Wintzell V; Dahlqwist E; Eliasson B; Svensson A-M; Franzen S; Gudbjornsdottir S; Hveem K; Jonasson C; Melbye M; Hviid A; Svanstrom H; Pasternak B
Article: DIABETOLOGIA. 2021;64(10):2204-2214
Use of incretin-based drugs and risk of cholangiocarcinoma: Scandinavian cohort study
Ueda P; Wintzell V; Melbye M; Eliasson B; Svensson A-M; Franzen S; Gudbjornsdottir S; Hveem K; Jonasson C; Svanstrom H; Pasternak B
Article: JAMA PEDIATRICS. 2021;175(4):394-403
Association Between Proton Pump Inhibitor Use and Risk of Asthma in Children
Wang Y-H; Wintzell V; Ludvigsson JF; Svanstrom H; Pasternak B
Article: JOURNAL OF INTERNAL MEDICINE. 2021;289(3):411-419
Direct oral anticoagulant use and risk of severe COVID-19
Flam B; Wintzell V; Ludvigsson JF; Martensson J; Pasternak B
Article: CLINICAL DRUG INVESTIGATION. 2020;40(12):1147-1154
Data Mining for Adverse Events of Tumor Necrosis Factor-Alpha Inhibitors in Pediatric Patients: Tree-Based Scan Statistic Analyses of Danish Nationwide Health Data
Wintzell V; Svanstrom H; Melbye M; Ludvigsson JF; Pasternak B; Kulldorff M
Article: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2020;29(9):1086-1092
Impact of variable look-back periods on the incidence rates of chronic diseases using real world data
Rosenlund M; Ekstrom N; Tornblom M; Wintzell V; Stark JH; Titievsky L
Article: DIABETES CARE. 2020;43(6):1326-1335
Use of Glucagon-Like Peptide 1 Receptor Agonists and Risk of Serious Renal Events: Scandinavian Cohort Study
Pasternak B; Wintzell V; Eliasson B; Svensson A-M; Franzen S; Gudbjornsdottir S; Hveem K; Jonasson C; Melbye M; Svanstrom H; Ueda P
Article: JAMA PEDIATRICS. 2020;174(6):543-551
Association Between Proton Pump Inhibitor Use and Risk of Fracture in Children
Wang Y-H; Wintzell V; Ludvigsson JF; Svanstrom H; Pasternak B
Article: THE BMJ. 2020;369:m1186
Use of sodium-glucose co-transporter 2 inhibitors and risk of serious renal events: Scandinavian cohort study
Pasternak B; Wintzell V; Melbye M; Eliasson B; Svensson A-M; Franzen S; Gudbjornsdottir S; Hveem K; Jonasson C; Svanstrom H; Ueda P
Article: THE LANCET GASTROENTEROLOGY AND HEPATOLOGY. 2019;4(11):845-853
Use of tumour necrosis factor-α inhibitors and the risk of serious infection in paediatric inflammatory bowel disease in Denmark: a nationwide cohort study
Wintzell V; Svanstrom H; Melbye M; Jess T; Olen O; Ludvigsson JF; Pasternak B
Article: THE BMJ. 2019;366:l4772
Use of sodium glucose cotransporter 2 inhibitors and risk of major cardiovascular events and heart failure: Scandinavian register based cohort study
Pasternak B; Ueda P; Eliasson B; Svensson A-M; Franzen S; Gudbjornsdottir S; Hveem K; Jonasson C; Wintzell V; Melbye M; Svanstrom H
Article: THE LANCET CHILD AND ADOLESCENT HEALTH. 2019;3(3):158-165
Association between use of azathioprine and risk of acute pancreatitis in children with inflammatory bowel disease: a Swedish-Danish nationwide cohort study
Wintzell V; Svanstrom H; Olen O; Melbye M; Ludvigsson JF; Pasternak B
Article: ANNALS OF TRANSPLANTATION. 2018;23:852-866
Healthcare Resource Use, Cost, and Sick Leave Following Kidney Transplantation in Sweden: A Population-Based, 5-Year, Retrospective Study of Outcomes: COIN
von Zur-Muhlen B; Wintzell V; Levine A; Rosenlund M; Kilany S; Nordling S; Wadstrom J
Visa fler

Alla övriga publikationer

Conference publication: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2023;31:8-9
Association of glucagon-like peptide-1 receptor agonists with serious liver events: Scandinavian cohort study
Engstrom A; Wintzell V; Melbye M; Svanstrom H; Eliasson B; Gudbjornsdottir S; Hveem K; Jonasson C; Hviid A; Pasternak B; Ueda P
Editorial comment: DIABETES CARE. 2022;45(5):e93-e96
Sodium-Glucose Cotransporter 2 Inhibitors and Risk of Bladder and Renal Cancer: Scandinavian Cohort Study
Ueda P; Svanstrom H; Hviid A; Eliasson B; Svensson A-M; Frazen S; Gudbjornsdottir S; Hveem K; Jonasson C; Wintzell V; Melbye M; Pasternak B
Conference publication: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2022;31:97
Sodium-glucose co-transporter 2 inhibitor treatment and risk of atrial fibrillation: Scandinavian cohort study
Engstrom A; Wintzell V; Melbye M; Hviid A; Eliasson B; Gudbjornsdottir S; Hveem K; Jonasson C; Svanstrom H; Pasternak B; Ueda P
Thesis / dissertation: 2021
Pharmacoepidemiologic studies of drug safety in pediatric chronic inflammatory disease
Wintzell, Viktor
Conference publication: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2020;29:451-452
Data mining for adverse events of tumor necrosis factor-alpha inhibitors in pediatric patients - A tree-based and treetemporal scan statistics analysis of Danish nationwide health data
Wintzell V; Svanstrom H; Melbye M; Ludvigsson JF; Pasternak B; Kulldorff M
Conference publication: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2020;29:452
Association between proton pump inhibitor use and risk of fracture in children
Wang Y-H; Wintzell V; Ludvigsson JF; Svanstrom H; Pasternak B
Letter: JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (JAMA). 2018;319(22):2333-2335
Oral Fluconazole in Pregnancy and Risk of Stillbirth and Neonatal Death
Pasternak B; Wintzell V; Furu K; Engeland A; Neovius M; Stephansson O
Conference publication: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2018;27:28-29
Assessment of misclassification bias due to short look-back periods in epidemiological studies of chronic disease incidence
Ekstrom N; Tornblom M; Titievsky L; Wintzell V; Stark J; Rosenlund M
Conference publication: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2018;27:30
Oral fluconazole in pregnancy and risk of stillbirth and neonatal death
Pasternak B; Wintzell V; Furu K; Engeland A; Neovius M; Stephansson O
Conference publication: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2018;27:196
Association between azathioprine use and risk of acute pancreatitis in pediatric inflammatory bowel disease: A nationwide Swedish cohort study
Wintzell V; Svanstrom H; Olen O; Melbye M; Ludvigsson JF; Pasternak B
Conference publication: EUROPEAN JOURNAL OF HEART FAILURE. 2017;19:55
Drug treatment patterns in patients newly diagnosed with heart failure: a retrospective population-based cohort study in Sweden
Wikstrom G; Lindmark K; Olofsson M; Stalhammar J; Bergman GJ; Tornblom M; Wintzell V; Wirta SB; Balas B; Boman K
Conference publication: EUROPEAN JOURNAL OF HEART FAILURE. 2017;19:54-55
Management of patients with heart failure with preserved versus reduced ejection fraction: a retrospective population-based cohort study in Sweden
Stalhammar J; Boman K; Olofsson M; Wikstrom G; Bergman GJ; Tornblom M; Wintzell V; Wirta SB; Proenca CC; Schlienger R; Lindmark K
Conference publication: EUROPEAN JOURNAL OF HEART FAILURE. 2017;19:54
Suboptimal dosing of common heart failure treatments in newly diagnosed patients with heart failure: a retrospective population-based cohort study in Sweden
Wikstrom G; Boman K; Olofsson M; Stalhammar J; Bergman GJ; Tornblom M; Wintzell V; Balas B; Corda S; Lindmark K
Conference publication: EUROPEAN JOURNAL OF HEART FAILURE. 2016;18:341
Dosing of heart failure treatments in newly diagnosed unselected patients in sweden: compliance with european society of cardiology guidelines
Wikstrom G; Boman K; Olofsson M; Lindmark K; Lahoz R; Corda S; Wintzell V; Linder R; Gondos A; Stalhammar J
Conference publication: EUROPEAN JOURNAL OF HEART FAILURE. 2016;18:195
A description of unselected patients with heart failure: a swedish population-based study
Stalhammar J; Boman K; Olofsson M; Lindmark K; Lahoz R; Corda S; Wintzell V; Linder R; Gondos A; Wikstrom G
Conference publication: EUROPEAN JOURNAL OF HEART FAILURE. 2016;18:54-55
Recent trends in diagnostic work-up among unselected patients newly diagnosed with heart failure: a Swedish population-based study
Stalhammar J; Boman K; Olofsson M; Lindmark K; Lahoz R; Corda S; Wintzell V; Linder R; Gondos A; Wikstrom G
Conference publication: EUROPEAN JOURNAL OF HEART FAILURE. 2016;18:48
Exposure to heart failure treatments in newly diagnosed patients in Sweden
Wikstrom G; Boman K; Olofsson M; Lindmark K; Lahoz R; Corda S; Wintzell V; Linder R; Gondos A; Stalhammar J
Meeting abstract: VALUE IN HEALTH. 2014;17(3):A48-A49
RESOURCE USE RELATED TO VERTEBRAL FRACTURES BASED ON DATA FROM ICUROS
Svedbom A; Wintzell V; Alekna V; Bianchi ML; Clark P; Diaz-Curiel M; Dimai HP; Lesnyak O; McCloskey E; Sanders KM; Tamulaitiene M; Thomas T; Borgstrom F; Kanis JA
Conference publication: OSTEOPOROSIS INTERNATIONAL. 2014;25:S109-S110
HOSPITALIZED AND NONHOSPUIALIZED VERTEBRAL FRACTURES: COMPARISON OF PATIENT DEMOGRAPHICS AND HEALTH RELATED QUALITY OF LIFE IMPLICATIONS
Svedbom A; Wintzell V; Alekna V; Tamulaitiene M; Bianchi ML; Clark P; Diaz-Curiel M; Dimai HP; Lesnyak O; McCloskey EV; Sanders KM; Thomas T; Borgstrom F; Kanis JA
Meeting abstract: VALUE IN HEALTH. 2013;16(7):A573-A574
THE RESOURCE USE RELATED TO HIP FRACTURES BASED ON DATA FROM ICUROS
Wintzell V; Ivergard M; Tanko LB; Barghout V; Svedbom A; Alekna V; Bianchi ML; Clark P; Diaz Curiel M; Dimai HP; Juerisson M; Lesnyak O; McCloskey E; Sanders KM; Thomas T; Borgstrom F; Kanis JA
Conference publication: ARTHRITIS & RHEUMATOLOGY. 2013;65:S520
The Quality Of Life and Resource Use Related To Hip Fractures Based On Data From The International Costs and Utilities Related To Osteoporotic Fractures Study.
Ivergard M; Wintzell V; Tanko LB; Barghout V; Svedbom A; Alekna V; Bianchi ML; Clark P; Diaz Curiel M; Dimai HP; Juerisson M; Lesnyak O; McCloskey E; Sanders KM; Thomas T; Borgstroem F; Kanis JA
Visa fler

Anställningar

Samordnare, Medicin, Solna, Karolinska Institutet, 2022-

Examina och utbildning

Medicine Doktorsexamen, Institutionen för medicin, Solna, Karolinska Institutet, 2021

Handledare

Arvid Engström, 2020

Om mig

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Handledare

Nyheter från KI

Kalenderhändelser från KI